We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+3.8%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$439M
AUM Growth
+$17M
(+4%)
Cap. Flow
+$2.49M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
34.44%
Holding
166
New
5
Increased
70
Reduced
71
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$1.81M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$1.55M |
| 3 |
Mastercard
MA
|
+$1.36M |
| 4 |
Qualcomm
QCOM
|
+$1.19M |
| 5 |
STKL
SunOpta
STKL
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$6.42M |
| 2 |
Walmart Inc
WMT
|
+$1.18M |
| 3 |
Intel
INTC
|
+$989K |
| 4 |
NXP Semiconductors
NXPI
|
+$936K |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$775K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.98% |
| 2 | Technology | 24.04% |
| 3 | Industrials | 17.33% |
| 4 | Consumer Staples | 10.98% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CVS Health
CVS
$122B
| $20.5M | 4.68% |
272,536
-2,230
| -0.8% | -$169K |
|
2
Procter & Gamble
PG
$339B
| $20.1M | 4.58% |
256,142
-444
| -0.2% | -$35.8K |
|
3
Johnson Controls International
JCI
$92.2B
| $15.7M | 3.59% |
301,228
+3,136
| +1% | +$156K |
|
4
Johnson & Johnson
JNJ
$625B
| $15.4M | 3.5% |
146,986
-2,952
| -2% | -$298K |
|
5
Novartis
NVS
$297B
| $15.3M | 3.49% |
188,789
+1,550
| +0.8% | +$122K |
|
6
Automatic Data Processing
ADP
$108B
| $14.6M | 3.32% |
209,425
+513
| +0.2% | +$35K |
|
7
Emerson Electric
EMR
$88.3B
| $13M | 2.95% |
195,454
-825
| -0.4% | -$55.5K |
|
8
GSK
GSK
$106B
| $13M | 2.95% |
194,022
+12
| +0% | +$812 |
|
9
Illumina
ILMN
$28.4B
| $11.9M | 2.71% |
68,583
-4,426
| -6% | -$660K |
|
10
Apple
AAPL
$4.57T
| $11.8M | 2.68% |
505,824
+24,504
| +5% | +$521K |
|
|
EMC
11
DELISTED
EMC CORPORATION
EMC
| $11.4M | 2.6% |
433,359
+14,937
| +4% | +$394K |
|
12
Rockwell Automation
ROK
$49B
| $10.8M | 2.46% |
86,393
+2,604
| +3% | +$321K |
|
13
Canadian National Railway
CNI
$76.6B
| $9.67M | 2.2% |
148,730
+3,100
| +2% | +$184K |
|
|
14
Teva Pharmaceuticals
TEVA
$41.2B
| $9.35M | 2.13% |
178,451
-15,160
| -8% | -$775K |
|
15
AptarGroup
ATR
$8.61B
| $8.3M | 1.89% |
123,820
+2,595
| +2% | +$173K |
|
|
16
Mastercard
MA
$493B
| $8.21M | 1.87% |
111,705
+18,365
| +20% | +$1.36M |
|
17
Corning
GLW
$143B
| $8.04M | 1.83% |
366,365
-28,420
| -7% | -$603K |
|
|
18
NXP Semiconductors
NXPI
$60.4B
| $7.98M | 1.82% |
120,551
-15,277
| -11% | -$936K |
|
19
Perrigo
PRGO
$1.78B
| $7.82M | 1.78% |
53,628
+7,313
| +16% | +$1.04M |
|
20
Labcorp
LH
$25.9B
| $7.75M | 1.76% |
88,095
+134
| +0.2% | +$11.6K |
|
21
Cisco
CSCO
$479B
| $7.66M | 1.74% |
308,034
-18,954
| -6% | -$452K |
|
|
22
Qualcomm
QCOM
$176B
| $7.49M | 1.71% |
94,573
+15,014
| +19% | +$1.19M |
|
23
Xylem
XYL
$28.1B
| $7.18M | 1.63% |
183,660
+12,360
| +7% | +$462K |
|
|
STKL
24
DELISTED
SunOpta
STKL
| $6.78M | 1.54% |
481,305
+92,400
| +24% | +$1.15M |
|
25
Stratasys
SSYS
$774M
| $6.58M | 1.5% |
57,892
-2,595
| -4% | -$254K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Reynders McVeigh Capital Management held 166 positions worth $439M, up 4% from $422M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Reynders McVeigh Capital Management's Q2 2014 filing shows 5 new, 70 increased, 71 reduced and 4 closed positions. Its largest new stake was MCGRAW-HILL FINANCIAL INC COM: 7,250 shares worth $602K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $6.42M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q2 2014 buy was MCGRAW-HILL FINANCIAL INC COM: 7,250 shares worth $602K.
- Reynders McVeigh Capital Management added most to Target in Q2 2014, an estimated $1.81M increase.
- Reynders McVeigh Capital Management's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $6.42M.
- Reynders McVeigh Capital Management fully exited Roper Technologies in Q2 2014, selling an estimated $232K.
- Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $439M portfolio in Q2 2014.
- Reynders McVeigh Capital Management opened 5 new positions and closed 4 in Q2 2014.
- Reynders McVeigh Capital Management's portfolio value rose 4% quarter-over-quarter to $439M.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.